Privia Health Group, Inc. (PRVA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the 2025 Annual Meeting of Stockholders held by Privia Health Group, Inc. on May 21, 2025. The meeting was conducted via live webcast.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and stockholder voting results.
Material Changes and Voting Results
Stockholders approved all three proposals submitted at the Annual Meeting:
- Proposal 1 (Election of Directors): Three Class III directors were elected for a term expiring at the 2028 Annual Meeting.
- Pamela Kimmet: 105,357,682 votes For; 1,261,343 votes Withheld.
- Patricia Maryland: 105,882,389 votes For; 736,636 votes Withheld.
- Shawn Morris: 102,054,977 votes For; 4,564,048 votes Withheld.
- Proposal 2 (Executive Compensation): Stockholders approved the compensation of named executive officers on an advisory, non-binding basis.
- 105,145,830 votes For; 1,431,629 votes Against; 41,566 Abstentions.
- Proposal 3 (Auditor Ratification): The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
- 111,333,432 votes For; 18,508 votes Against; 35,893 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the Annual Meeting outcomes.
Key Facts for Investor Verification
- Confirmation that PricewaterhouseCoopers LLP is the appointed auditor for the fiscal year ending December 31, 2025.
- Verification of the new board composition, specifically the three newly elected Class III directors.
- Review of the full proxy statement for detailed executive compensation metrics referenced in Proposal 2.
- Check for any subsequent filings regarding the resignation or removal of directors, as terms are subject to earlier termination.